Gene · 8493
Papers2,396
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,396
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCPH1 and DNA Damage Response Pathway Genes as Candidate Susceptibility Loci in Hereditary Breast Cancer. | Diagnostics (Basel) | 2026 | 42793752 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients With Heart Failure With Preserved Ejection Fraction. | Circ Heart Fail | 2026 | 42765309 | PubTator, text mining | PubMed |
| SelO functions as a tumor suppressor through AMPylating Cdk5rap3. | Proc Natl Acad Sci U S A | 2026 | 42735321 | PubTator, text mining | PubMed |
| Cancer treatment alters mutant selection in normal esophagus. | Nat Genet | 2026 | 42728384 | PubTator, text mining | PubMed |
| Diffuse intrinsic pontine glioma in the era of H3 K27-altered diffuse midline glioma. | Crit Rev Oncol Hematol | 2026 | 42692100 | PubTator, text mining | PubMed |
| TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy. | Leukemia | 2026 | 42637877 | PubTator, text mining | PubMed |
| Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations. | Bioinformatics | 2026 | 42635246 | PubTator, text mining | PubMed |
| Weekly Metronomic Venetoclax and Decitabine/Cedazuridine in Acute Myeloid Leukemia Patient Declining Blood Transfusion. | Case Rep Oncol | 2026 | 42626761 | PubTator, text mining | PubMed |
| Aryl hydrocarbon receptor modulates dysregulatory inflammatory responses in human retinal pigment epithelial cells. | Biochem Biophys Res Commun | 2026 | 42617404 | PubTator, text mining | PubMed |
| Late acquisition of BCR::ABL1 during clonal evolution of SAMD9-associated MDS with phenotypic shift from AML to B-ALL. | Int J Hematol | 2026 | 42533241 | PubTator, text mining | PubMed |
| Characteristics of donor and recipient clonal hematopoiesis in nonmyeloablative transplant for sickle cell disease. | Blood | 2026 | 42526888 | PubTator, text mining | PubMed |
| Retraction Note: Gamma-H2AX upregulation caused by Wip1 deficiency increases depression-related cellular senescence in hippocampus. | Sci Rep | 2026 | 42521718 | PubTator, text mining | PubMed |
| Clinical Impact and Dynamics of Clonal Hematopoiesis with 177Lu-PSMA-617 Therapy in Advanced Prostate Cancer. | J Nucl Med | 2026 | 42463292 | PubTator, text mining | PubMed |
| Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma. | Cancers (Basel) | 2026 | 42449578 | PubTator, text mining | PubMed |
| Clonal hematopoiesis of indeterminate potential (CHIP)-a pivotal contributor of aging and related disorders. | Ann Transl Med | 2026 | 42434778 | PubTator, text mining | PubMed |
| Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity. | Cancer Res | 2026 | 42378680 | PubTator, text mining | PubMed |
| Influence of PPM1D Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma Patients. | Biomedicines | 2026 | 42351820 | PubTator, text mining | PubMed |
| KDM4D enhances radiosensitivity in esophageal squamous cell carcinoma through the SRBD1/RPL11/c-Myc/WIP1/CHK1 axis. | Am J Transl Res | 2026 | 42325777 | PubTator, text mining | PubMed |
| Combined inhibition of PLK4 and PPM1D promotes cell death in cancer cells with 17q amplification. | Cancer Cell Int | 2026 | 42316241 | PubTator, text mining | PubMed |
| Distinct Proteasomal Pathways Drive Oncogenic PPM1D Activation. | bioRxiv | 2026 | 42282570 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8493/papers